Silver Book reference

2009 Alzheimer’s Disease Facts and Figures

13 Matching Facts

Search matching Facts:
No results to display
    • Medicaid recipients with Alzheimer’s disease have spending that is 9 times higher than for those without the disease.  
    • Medicare beneficiaries with Alzheimer’s disease have payments that are 3 times higher than beneficiaries without the disease.  
    • In 2008, the economic value of care provided by an unpaid caregiver of someone with Alzheimer’s disease or other dementia was $94 billion.  
    • In 2004, the average per person payments for hospice care of beneficiaries age 65 and older with Alzheimer’s disease or other dementia were 8 times higher than for other beneficiaries…  
    • Out-of-pocket costs for Medicare beneficiaries age 65 and older with Alzheimer’s disease and other dementias who were living in the community were 1.2 times higher than the average for all…  
    • In 2004, average Medicaid payments per person for Medicare beneficiaries age 65 and older with Alzheimer’s disease and other dementias were more than 9 times as high as the average…  
    • In 2004, total per-person payments for Medicare beneficiaries age 65 and older with Alzheimer’s disease and other dementias (including all sources for health and long-term care) were $33,007–compared to $10,603…  
    • Alzheimer’s disease triples the healthcare costs of Americans age 65 and older.  
    • In 2005, the direct costs to Medicare and Medicaid for individuals with Alzheimer’s disease and other dementias, plus the estimated indirect costs to businesses of employees who were caregivers to…  
    • Recent studies suggest that a low-fat diet which is rich in fruits and vegetables may support brain health. Other studies suggest that remaining socially active and intellectually engaged may also…  
    • Some studies have indicate that the management of high cholesterol, type 2 diabetes, high blood pressure, overweight or obesity, and other cardiovascular risk factors may help avoid or delay cognitive…  
    • Studies have shown that active medical management of Alzheimer’s disease can significantly improve quality-of-life for the individual through all stages of the disease.  
    • The U.S. Food and Drug Administration has approved 5 drugs for the treatment of Alzheimer’s disease. These drugs have been found to temporarily slow the worsening of Alzheimer’s symptoms for…